NF1-PN Patient Marketing Intern (Undergraduate) jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alexion Pharmaceuticals, Inc. · 2 days ago

NF1-PN Patient Marketing Intern (Undergraduate)

Alexion Pharmaceuticals, Inc. is seeking an intern for their Patient Marketing team at the AstraZeneca Rare Disease site in Boston. The role involves creating social media content, identifying gaps in patient engagement, and collaborating with community outreach efforts.

BiotechnologyHealth CareMedicalTherapeutics
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Work with agency partner to create social media posts in alignment with brand strategy
Work with Patient Marketing lead to identify gaps in patient & caregiver engagement and propose additional new resources to address those needs
Work with field PEM (patient education manager team) to identify additional opportunities for community engagement and education and optimize our current tactical plan to enhance those critical resources

Qualification

Social media knowledgeMS Office ProficiencyPublic speakingPresentation designCollaboration

Required

Sophomore and Junior students majoring in Business Administration, Marketing, or a related field
Candidates must have an expected graduation date after August 2026
Social media knowledge with key customer platforms (Facebook, X, TikTok, YouTube, Reddit)
MS Office Proficiency
Enthusiasm for collaboration, cross-functional projects, public speaking, and presentation design
US Work Authorization is required at time of application
Ability to report onsite to the Seaport neighborhood in Boston, MA 3 days per week

Benefits

Short-term incentive bonus opportunity
Equity-based long-term incentive program (salaried roles)
Retirement contribution (hourly roles)
Commission payment eligibility (sales roles)
Qualified retirement program [401(k) plan]
Paid vacation and holidays
Paid leaves
Health benefits including medical, prescription drug, dental, and vision coverage

Company

Alexion Pharmaceuticals, Inc.

company-logo
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.

Funding

Current Stage
Public Company
Total Funding
$5.8M
2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO

Leadership Team

leader-logo
Frederic Chereau
SVP, Strategy and Business Development
linkedin
leader-logo
Imran Shakur
Director, IRT and Technology Lead
linkedin
Company data provided by crunchbase